A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
Carl J. Pepine(Cedars-Sinai Medical Center), for the INVEST Investigators(Unknown), George L. Bakris(Pennsylvania State System of Higher Education), H. Robert Kolb(University of Florida), Franz H. Messerli(University of Bern), D García-Barreto(Instituto de Cardiología y Cirugía Cardiovascular), Heather A. Bristol(University of Florida), Mátyás Keltai, José L. Cangiano, Rhonda M. Cooper‐DeHoff(University of Florida), Eileen Handberg(University of Florida), Giuseppe Mancia(University of Milano-Bicocca), Jerome D. Cohen(Brigham and Women's Hospital), William W. Parmley(University of California, San Francisco), Peter R. Kowey(Lankenau Institute for Medical Research), Ronald G. Marks(University of Florida), Serap Erdine(University of Milan)
Cited by 1,291
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k